Mission & Strategy

Our Mission

SkyePharma’s mission is to deliver a clinical benefit for patients by using its multiple delivery technologies to create enhanced versions of existing pharmaceutical products as well as products incorporating new chemical entities.

Our Business Strategy

SkyePharma’s business strategy is to become one of the world’s leading speciality drug delivery companies using its proprietary technologies and competitive capabilities, particularly in the areas of oral and inhalation drug delivery, to produce new formulations of existing approved pharmaceutical ingredients that meet market needs and provide benefits to patients. Whilst continuing to benefit from existing approved products, the Group aims to enhance its product pipeline by identifying additional candidate products through its own research as well as collaborations with partner companies.

Copyright 2009, SkyePharma. All Rights Reserved.

SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 105 Piccadilly, London, W1J 7NJ, United Kingdom